The careful choice of nanoparticles as targets and in drug delivery routes enhances therapeutic efficacy in cancer. Nanoparticle-Based Drug Delivery in Cancer Treatment discusses nanotechnological developments of interfering RNA-based nanoparticles, delivery vehicles, and validated therapeutic RNAi-molecular target interactions and explains the results of clinical and preclinical trials. The book also gives strategies for universal methods of constructing hybrid organic-inorganic nanomaterials that can be widely applied in the biomedical field.

Key Features:

• Reviews recent advances of nanoparticle-mediated siRNA delivery systems and their application in clinical trials for cancer therapy
• Focuses on material platforms that establish NPs and both localized and controlled gene silencing
• Emphasizes the most promising systems for clinical application
• Surveys progress in nanoparticle-based nanomedicine in cancer treatment
• Describes the most advanced of the nonviral nanocarriers for delivery of oligonucleotides to malignant blood cancer cells

This book is a valuable resource for researchers, professors, and students researching drug delivery, gene carriers, cancer therapy, nanotechnology, and nanomaterials.